Medline IPO: Business and Risks

Jim breaks down Medline's IPO, growth, private-equity control, and why he won't buy the pop.

Play episode from 12:56

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!